Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT
Clinical trial NCT00646321 · COMPLETED
Trial details
- NCT number
- NCT00646321
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.